The antisynthetase syndrome: A cause of rapidly progressive interstitial lung disease;Syndrome des antisynthétases: Une cause de pneumopathie interstitielle rapidement progressive

Revue Medicale Suisse

Volumn 3, Issue 134, 2007, Pages 2675-2681

  Jordan Greco, Anne Sophie ^a   Métrailler, Jean Claude ^a   Dayer, Eric ^b  

^a Hopital de Sierre   (Switzerland)

^b Institut Central des Hopitaux Valaisans   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; METHYLPREDNISOLONE; PREDNISONE;

ACUTE RESPIRATORY FAILURE; ADULT; ANTISYNTHETASE SYNDROME; ARTICLE; CASE REPORT; COMBINATION CHEMOTHERAPY; CORTICOSTEROID THERAPY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL LUNG DISEASE; LUNG FUNCTION; REMISSION;

ADRENAL CORTEX HORMONES; ANTIBODIES, ANTINUCLEAR; ARTHRITIS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG DISEASES, INTERSTITIAL; MIDDLE AGED; MYOSITIS; RESPIRATORY INSUFFICIENCY; SYNDROME;

EID: 37049009082     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. ** Imbert-Masseau A, Hamidou M, Agard C, et al. Antisynthetase syndrome, review. Joint Bone Spine 2003;70:161-8.
2. * Clawson K, Oddis CV. Adult respiratory distress syndrome in polymyositis patients with the anti-Jo1 antibody. Arthritis Rheum 1995;38:1519-23.
3. Marie I, Dominique S. Atteinte pulmonaire au cours des polymyosites et des dermatomyosites. Presse Med 2006;35:683-95.
4. Tomsic M, Sifrer F. Acute respiratory distress syndrome in a polymyositis patient with the anti-Jo-1 antibody. Wien Klin Wochenschr 2000;112:728-31.
5. ** Cottin V, Capron F, Grenier P, Cordier JF. Pneumopathies interstitielles diffuses idiopathiques. Rev Mal Respir 2004;21:299-318.
6. Legout L, Fauchais AL, Hachulla E, et al. Le syndrome des antisynthétases : un sous-groupe des myopathies inflammatoires à ne pas méconnaître. Rev Med Interne 2002;23:273-82.
7. Cottin V, Thivolet-Bejui F, Reynaud-Gaubert M, et al et le groupe d'études et de recherche sur les maladies orphelines pulmonaires. Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis. Eur Respir J 2003;22:245-50.
8. Marie I, Hachulla E, Cherin P, et al. Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 2002;47:614-22.
9. Takada K, Nagasaka K, Miyasaka N. Polymyositis/dermatomyositis and intersititial lung disease : A new therapeutic approach with T-cell-specific immunosuppressants. Autoimmunity 2005;38:383-92.
10. Sauty A, Rochat Th, Schoch OD, et al. Pulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-jo1 antibodies. Eur Respir J 1997;10:2907-12.
11. * Schnabel A, Reuter M, Biederer J, et al. Interstitial lung disease in polymyositis and dermatomyositis : Clinical course and response to treatment. Semin Arthritis Rheum 2003;32:273-84.
12. Kameda H, Nagasawa H, Ogawa H, et al. Combination therapy with corticosteroids, cyclosporin A and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis. J Rheumatol 2005;32:1719-26.
13. Tellus MM, Buchanan RRC, Effective treatment of anti Jo1 antibody-positive polymyositis with cyclosporin. Br J Rheumatol 1995;34:1187-8.
14. Inase N, Sawada M, Ohtani Y, et al. Cyclosporin A followed by the treatment of acute exacerbation of idiopathic pulmonary fibrosis with corticosteroid. Intern Med 2003;42:565-70.
15. Oddis CV, Sciurba FC, Elmagd KA, Starzl TE. Tacrolimus in refractory polymyositis with interstitial lung disease. Lancet 1999;353:1762-3.